Chronic neuropathic pain: Mechanisms and treatment

Clinical Journal of Pain

Volumn 16, Issue 3 SUPPL., 2000, Pages

  Attal, N ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Neuropathic pain; Pathophysiology; Randomized controlled trials; Treatment

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; CODEINE; DESIPRAMINE; DEXTROMETHORPHAN; FENTANYL; FLUOXETINE; GABAPENTIN; IMIPRAMINE; KETAMINE; LAMOTRIGINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEXILETINE; MIANSERIN; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; NORTRIPTYLINE; OPIATE DERIVATIVE; OXYCODONE; PAROXETINE; PHENYTOIN; TRAMADOL; UNINDEXED DRUG; VALPROIC ACID;

ALLODYNIA; CHRONIC PAIN; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; HYPERALGESIA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0033826271     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200009001-00003     Document Type: Review

References (163)

1. Overview of the mechanisms of neuropathic pain
2. Neuropathic pain: Aetiology, symptoms, mechanisms and management
3. Postherpetic neuralgia: Irritable nociceptors and deafferentation
4. Treatment options in postherpetic neuralgia
5. Treatment options in painful diabetic neuropathy
6. The pathophysiology of damaged peripheral nerve
7. Microelectrode recordings from transected nerves in amputees with phantom limb pain
8. Paraesthesiae: Abnormal impulse generation in sensory nerve fibers in man
9. Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions
10. Dynamic and static components of mechanical hyperalgesia in human hairy skin
11. Myelinated afferents signal the hyperalgesia associated with nerve injury
12. Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence
13. Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviours in a rat model of peripheral mononeuropathy
14. NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride
15. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo
16. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation
17. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia
18. The effect of peripheral nerve injury on dorsal root potentials and on transmission of afferent signals into the spinal cord
19. The inhibition of nitric-oxide activated poly(ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat
20. Molecular signals responsible for the reorganization of the synaptic circuitry of the dorsal horn after peripheral nerve injury: The mechanisms of tactile allodynia
21. Peripheral nerve injury triggers central sprouting of myelinated afferents
22. Quantitative sensory testing in patients with painful or painless peripheral neuropathy due to HIV infection
23. The treatment of postherpetic neuralgia
24. Note preliminaire sur l'action de l'imipramine clans les etats douloureux
25. Depression masquerading as diabetic neuropathy
26. Nortryptiline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study
27. Amitryptiline relieves diabetic neuropathy pain in patients with normal or depressed mood
28. Efficacy of desipramine in painful diabetic neuropathy: A placebo-controlled trial
29. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy
30. Imipramine treatment of painful diabetic neuropathy
31. Imipramine treatment in diabetic neuropathy: Relief of subjective symptoms without changes in peripheral and autonomic nerve function
32. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy
33. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double blind cross over study
34. Concentration response relationship in paroxetine treatment of diabetic neuropathy. A patient-blinded dose escalation study
35. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy
36. The effect of mianserin on the symptoms of diabetic neuropathy
37. Amitriptyline versus placebo in post-herpetic neuralgia
38. Association of pain relief with drug side effects in post-herpetic neuralgia: A single-dose study of clonidine, codeine, ibuprofen and placebo
39. Desipramine relieves postherpetic neuralgia
40. An open and double-blind cross-over study on the efficacy of clomipramine (Anafranil) in patients with painful mono- and polyneuropathies
41. A randomized, within patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain
42. Central post-stroke pain - A controlled trial of amitriptyline and carbamazepine
43. Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial
44. Amitriptyline versus maprotiline in postherpetic neuralgia: A randomised, double blind, cross over study
45. Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy
46. Venlafaxine use in the treatment of diabetic peripheral neuropathic pain
47. A systematic review of antidepressants in neuropathic pain
48. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms
49. Dose-response for analgesic effect of amitriptyline in chronic pain
50. Pathophysiology of postherpetic neuralgia: Towards a rational treatment
51. Antidepressant-induced analgesia in chronic non-malignant pain: A meta-analysis of 39 placebo-controlled studies
52. Antidepressants as analgesics
53. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats
54. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat
55. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds
56. Treatment of diabetic neuropathy with diphenylhydantoin
57. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: Lidocaine, carbamazepine, and mexiletine
58. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (tegretol): Double blind crossover trial
59. Tegretol in the treatment of diabetic neuropathy
60. Nortriptyline-fluphenazine versus carbamazepine in the symptomatic treatment of diabetic neuropathy
61. Carbamazepine in the treatment of neuralgia
62. Relief of pain of Fabry's disease by diphenylhydantoin
63. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy
64. Phenytoin in the treatment of diabetic symmetrical polyneuropathy
65. Valproate for treatment of chronic central pain after spinal cord injury: A double-blind cross-over study
66. Anticonvulsant drugs used in the treatment of lancinating pain. A comparison
67. Intravenous infusion of phenytoin relieves neuropathic pain: A randomized, double-blinded, placebo-controlled, crossover study
68. A summary of mechanistic hypotheses of gabapentin pharmacology
69. Update on the mechanism of action of antiepileptic drugs
70. Gabapentin in the treatment of postherpetic neuralgia
71. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus
72. Randomized double blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain
73. Nonepileptic uses of gabapentin
74. Effects of the anticonvulsant gabapentin on peripheral and central neuropathic pain: A pilot study
75. Gabapentin in the treatment of painful diabetic neuropathy: A placebo controlled, double blind, crossover trial
76. Lamotrigine in the treatment of painful diabetic neuropathy
77. Lamotrigine in the treatment of painful diabetic neuropathy: A randomized, placebo-controlled trial
78. The analgesic efficacy of lamotrigine in central post-stroke pain
79. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: A randomised, double-blind, placebo controlled trial
80. Topiramate relieves refractory intercostal neuralgia
81. Topiramate, a novel antiepileptic drug, in neuropathic pain
82. One year's experience with intravenous procaine
83. Analgesic responses to IV lidocaine
84. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury
85. Intravenous lidocaine infusion. A new treatment of chronic painful diabetic neuropathy?
86. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia
87. Lidocaine test in neuralgia
88. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia
89. Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury
90. Intravenous lidocaine in central pain. A double-blind placebo-controlled psycho-physical study
91. Positive symptoms in multiple sclerosis: Their treatment with sodium channel blockers, lidocaine and mexiletine
92. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: A prospective study
93. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy
94. Response of central pain syndromes of intravenous lidocaine
95. Analgesic concentrations of lidocaine suppress tonic A-delta and C-fiber discharges produced by acute injury
96. Central effects of systemic lidocaine mediated by glycine spinal receptors: An iontophoretic study in the rat spinal cord
97. The systemic administration of local anesthetics produces a selective depression of C-afferent fiber evoked activity in the spinal cord
98. The use of oral mexiletine for the treatment of pain after peripheral nerve injury
99. Mexiletine for treatment of chronic painful diabetic neuropathy
100. Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group
101. Mexiletine in the treatment of diabetic neuropathy
102. Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy
103. Mexiletine for HIV-infected patients with painful peripheral neuropathy: A double-blind placebo-controlled crossover trial
104. Effect of mexiletine on spinal cord injury dysesthetic pain
105. Topical lidocaine gel relieves postherpetic neuralgia
106. Lidocaine patch: Double-blind controlled study of a new treatment method for postherpetic neuralgia
107. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: Results of an enriched enrollment study
108. Effects of EMLA cream on spontaneous and evoked pains in post-herpetic neuralgia
109. Postherpetic neuralgia: Pathogenesis, treatment and prevention
110. Opioid therapy for chronic nonmalignant pain: A review of the critical issues
111. Are opioids effective in relieving neuropathic pain?
112. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia
113. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
114. Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain
115. Randomised double-blind active-placebo controlled crossover trial of intravenous fentanyl in neuropathic pain
116. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia
117. Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain
118. Chronic opioid therapy as alternative treatment for postherpetic neuralgia
119. Prolonged treatment with transdermal fentanyl in neuropathic pain
120. Double blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy
121. Tramadol relieves pain and allodynia in polyneuropathy: A randomised double blind controlled trial
122. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy
123. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study
124. Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term follow-up
125. Treatment of painful diabetic neuropathy with capsaicin 0.075%
126. Topical capsaicin treatment for post-herpetic neuralgia
127. Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients
128. A double blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy
129. Does capsaicin relieve the pain of diabetic neuropathy?
130. Double blind placebo controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy
131. A randomized vehicle controlled trial of topical capsaicin in the treatment of postherpetic neuralgia
132. Topical capsaicin in painful diabetic neuropathy. Effects on sensory function
133. Capsaicin: Actions on nociceptive C fibres and therapeutic potential
134. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in postherpetic neuralgia, diabetic neuropathy and osteoarthritis
135. The capsaicin receptor: A heat-activated ion channel in the pain pathway
136. Responses of chronic neuropathic pain syndromes to ketamine: A preliminary study
137. The effect of ketamine on phantom pain: A central neuropathic disorder maintained by peripheral input
138. Clinical experience with oral ketamine
139. Randomised controlled trials of oral ketamine in patients with chronic pain
140. Dextromethorphan for the treatment of neuropathic pain: A double-blind randomised crossover trial with integral n-of-1 design
141. High dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia
142. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: A double-blind randomized, placebo controlled trial
143. AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans
144. Transdermal clonidine versus placebo in painful diabetic neuropathy
145. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design
146. Efficacy and safety of non-steroidal anti-inflammatory drugs in the therapy of diabetic neuropathy
147. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes
148. A new topical treatment for acute herpetic neuralgia and post-herpetic neuralgia: The aspirin/diethyl ether mixture
149. Topical aspirin/diethyl ether versus indomethacin and diclofenac/diethyl ether mixtures in postherpetic neuralgia: A double blind placebo controlled study
150. Aspirin in chlorophorm for the topical treatment of postherpetic neuralgia: A double blind trial
151. Baclofen in the treatment of trigeminal neuralgia: Double-blind study and long-term follow-up
152. Baclofen as an analgesic in chronic peripheral nerve disease
153. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study
154. The neurochemistry of central pain: Evidence from clinical studies, hypothesis and therapeutic implications
155. Effect of intravenous sodium amytal on cutaneous sensory abnormalities, spontaneous pain and algometric pain pressure thresholds in neuropathic pain patients: A placebo-controlled study
156. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy
157. Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients
158. Anticonvulsant drugs for management of pain: A systematic review
159. Systemic local anaesthetic-type drugs in chronic pain: A systematic review
160. The effectiveness of topically applied capsaicin: A meta-analysis
161. Intravenous phentolamine test: Diagnostic and prognostic use in reflex sympathetic dystrophy
162. Systemic alpha-adrenergic blockade with phentolamine: A diagnostic test for sympathetically maintained pain
163. Phentolamine sympathetic block in painful polyneuropathies. II. Further questioning of the concept of 'sympathetically maintained pain'